Molecular Imaging as a critical tool in discovery of the basis of tumour heterogeneity and developing novel therapies to overcome therapeutic resistance

点击翻译按钮获取中文摘要

Determining treatment options for cancer currently relies on the size and extent of tumour deposits on imaging, combined with a biopsy. However, this approach fails to recognise the ability of tumours to evolve components that are, or become, resistant to treatment. My laboratory uses advanced molecular imaging, targeted biopsies, animal models and genetic analysis to detect and understand the basis of such resistance and thereby develop new, targeted treatments to improve patient outcomes.